-
1
-
-
0034183236
-
Impact of vaginal antifungal products on utilization of health care services: Evidence from physician visits
-
Lipsky MS, Waters T, Sharp LK. Impact of vaginal antifungal products on utilization of health care services: evidence from physician visits. J Am Board Fam Pract 2000; 13: 178-182.
-
(2000)
J. Am. Board Fam. Pract.
, vol.13
, pp. 178-182
-
-
Lipsky, M.S.1
Waters, T.2
Sharp, L.K.3
-
2
-
-
0343467356
-
Office visits to obstetricians and gynecologists: United States, 1989-1990
-
National Center for Health Statistics: Hyattsville, Maryland
-
Schappert SM. Office visits to obstetricians and gynecologists: United States, 1989-1990. Advance Data from Vital and Health Statistics, No. 223. National Center for Health Statistics: Hyattsville, Maryland; 1992.
-
(1992)
Advance Data from Vital and Health Statistics
, Issue.223
-
-
Schappert, S.M.1
-
3
-
-
0026091708
-
Epidemiology of vaginitis
-
Kent HL. Epidemiology of vaginitis. Am J Obstet Gynecol 1991; 165: 1168.
-
(1991)
Am. J. Obstet. Gynecol.
, vol.165
, pp. 1168
-
-
Kent, H.L.1
-
4
-
-
0029080559
-
The epidemiology of vulvovaginal candidiasis among university students
-
Geiger AM, Foxman B, Gillespie BW. The epidemiology of vulvovaginal candidiasis among university students. Am J Pub Health 1995; 85: 1146-1148.
-
(1995)
Am. J. Pub. Health
, vol.85
, pp. 1146-1148
-
-
Geiger, A.M.1
Foxman, B.2
Gillespie, B.W.3
-
5
-
-
0034128410
-
Candida vaginitis: Self-reported incidence and associated costs
-
Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel J. Candida vaginitis: self-reported incidence and associated costs. Sex Transm Dis 2000; 27: 230-235.
-
(2000)
Sex Transm. Dis.
, vol.27
, pp. 230-235
-
-
Foxman, B.1
Barlow, R.2
D'Arcy, H.3
Gillespie, B.4
Sobel, J.5
-
6
-
-
0025106118
-
The limited value of symptoms and signs in the diagnosis of vaginal infections
-
Schaaf VM, Perez-Stabel EJ, Borchart K. The limited value of symptoms and signs in the diagnosis of vaginal infections. Arch Intern Med 1990; 150: 1929-1933.
-
(1990)
Arch. Intern. Med.
, vol.150
, pp. 1929-1933
-
-
Schaaf, V.M.1
Perez-Stabel, E.J.2
Borchart, K.3
-
7
-
-
0037052352
-
Sexually transmitted diseases treatment guidelines 2002
-
Centers for Disease Control and Prevention
-
Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR 2002; 51(No. RR-6): 1-82.
-
(2002)
MMWR
, vol.51
, Issue.RR-6
, pp. 1-82
-
-
-
8
-
-
0029563953
-
The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: The case of vaginal antifungal products
-
Gurwitz JH, McLaughlin TJ, Fish LS. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products. Health Serv Res 1995; 30: 672-685.
-
(1995)
Health Serv. Res.
, vol.30
, pp. 672-685
-
-
Gurwitz, J.H.1
McLaughlin, T.J.2
Fish, L.S.3
-
9
-
-
0029955310
-
Clinical and cost considerations in the pharmacotherapy of vulvovaginal candidiasis
-
Fong IW. Clinical and cost considerations in the pharmacotherapy of vulvovaginal candidiasis. Pharmacoeconomics 1996; 9: 497-505.
-
(1996)
Pharmacoeconomics
, vol.9
, pp. 497-505
-
-
Fong, I.W.1
-
10
-
-
0034038014
-
Self-medication with vaginal antifungal drugs: Physicians' experiences and women's utilization patterns
-
Sihvo S, Ahonen R, Mikander H, Hemminki E. Self-medication with vaginal antifungal drugs: physicians' experiences and women's utilization patterns. Fam Pract 2000; 17: 145-149.
-
(2000)
Fam. Pract.
, vol.17
, pp. 145-149
-
-
Sihvo, S.1
Ahonen, R.2
Mikander, H.3
Hemminki, E.4
-
11
-
-
0029890455
-
Women's use of over-the counter antifungal medications for gynecologic symptoms
-
Ferris DG, Dekle C, Litaker MS. Women's use of over-the counter antifungal medications for gynecologic symptoms. J Fam Pract 1996; 42: 595-600.
-
(1996)
J. Fam. Pract.
, vol.42
, pp. 595-600
-
-
Ferris, D.G.1
Dekle, C.2
Litaker, M.S.3
-
12
-
-
0036315884
-
Facts and myths on recurrent vulvovaginal candidosis - A review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy
-
Mardh PA, Rodrigues AG, Genc M, Novikova N, Martinez-de-Oliveira J, Guaschino S. Facts and myths on recurrent vulvovaginal candidosis - a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy. Int J STD AIDS 2002; 13: 522-539.
-
(2002)
Int. J. STD AIDS
, vol.13
, pp. 522-539
-
-
Mardh, P.A.1
Rodrigues, A.G.2
Genc, M.3
Novikova, N.4
Martinez-de-Oliveira, J.5
Guaschino, S.6
-
13
-
-
0036189890
-
Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis
-
Ferris DG, Nyirjesy P, Sobel JD, Soper D, Pavletic A, Litaker MS. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol 2002; 99: 419-425.
-
(2002)
Obstet. Gynecol.
, vol.99
, pp. 419-425
-
-
Ferris, D.G.1
Nyirjesy, P.2
Sobel, J.D.3
Soper, D.4
Pavletic, A.5
Litaker, M.S.6
-
14
-
-
0002798352
-
Candidosis of the genitalia
-
Odds FC 2nd edn, Bailliere Tindall: London
-
Candidosis of the genitalia. In Candida and Candidosis : A Review and Bibliography. Odds FC 2nd edn, Bailliere Tindall: London, 1988: 124-135.
-
(1988)
Candida and Candidosis: A Review and Bibliography
, pp. 124-135
-
-
-
16
-
-
0036827785
-
Vaginitis due to Candida krusei: Epidemiology, clinical aspects and therapy
-
Singh S, Sobel JD, Bhargova P, Boikov D, Vazquez JA. Vaginitis due to Candida krusei: epidemiology, clinical aspects and therapy. Clin Infect Dis 2002; 35: 1066-1070.
-
(2002)
Clin. Infect. Dis.
, vol.35
, pp. 1066-1070
-
-
Singh, S.1
Sobel, J.D.2
Bhargova, P.3
Boikov, D.4
Vazquez, J.A.5
-
17
-
-
0032855448
-
Adolescent gynecology, part II: The sexually active adolescent
-
Nyirjesy P. Adolescent gynecology, part II: the sexually active adolescent. Pediatr Clinics Nth Am 1999; 46: 733-745.
-
(1999)
Pediatr. Clinics Nth. Am.
, vol.46
, pp. 733-745
-
-
Nyirjesy, P.1
-
18
-
-
0004516992
-
Sample design, sampling variance and estimation procedures for the National Ambulatory Medical Care Survey
-
Bryant E, Shimizu I. Sample design, sampling variance and estimation procedures for the National Ambulatory Medical Care Survey. Vital Health Stat 2 1988; 108: 575-583.
-
(1988)
Vital Health Stat. 2
, vol.108
, pp. 575-583
-
-
Bryant, E.1
Shimizu, I.2
-
19
-
-
0018438935
-
A reason for visit classification for ambulatory care: National Center for Health Statistics
-
Schneider D, Appleton L, McClemore T. A reason for visit classification for ambulatory care: National Center for Health Statistics. Vital Health Stat 2 1979; 78: 1-63.
-
(1979)
Vital Health Stat. 2
, vol.78
, pp. 1-63
-
-
Schneider, D.1
Appleton, L.2
McClemore, T.3
-
21
-
-
0020108806
-
The collection and processing of drug information: National Ambulatory Medical Care Survey, 1980
-
Koch H, Campbell W. The collection and processing of drug information: National Ambulatory Medical Care Survey, 1980. Vital Health Stat 2 1982; 90: 1-90.
-
(1982)
Vital Health Stat. 2
, vol.90
, pp. 1-90
-
-
Koch, H.1
Campbell, W.2
-
22
-
-
0038129111
-
-
Research Triangle Institute. Research Triangle Institute: Research Triangle Park, NC
-
Research Triangle Institute (2002). SUDAAN user's manual, release 8.0. Research Triangle Institute: Research Triangle Park, NC.
-
(2002)
SUDAAN User's Manual, Release 8.0
-
-
-
24
-
-
0032559122
-
1998 Guidelines for treatment of sexually transmitted diseases
-
Centers for Disease Control and Prevention
-
Centers for Disease Control and Prevention. 1998 Guidelines for treatment of sexually transmitted diseases. MMWR 1998; 47(No. RR-1): 1-116.
-
(1998)
MMWR
, vol.47
, Issue.RR-1
, pp. 1-116
-
-
-
25
-
-
13844252231
-
Pfizer launches Diflucan (fluconazole), the only prescription treatment for vaginal candidiasis
-
Pharmacy Business News. Available at
-
Pharmacy Business News. Pfizer launches Diflucan (fluconazole), the only prescription treatment for vaginal candidiasis. Available at: http://www.rphlink.com/diflucanpfizer.html.
-
-
-
-
26
-
-
0035989218
-
Treatment of vaginal Candida infections
-
Sobel JD. Treatment of vaginal Candida infections. Expert Opin Pharmacother 2002; 3: 1059-1065.
-
(2002)
Expert Opin. Pharmacother.
, vol.3
, pp. 1059-1065
-
-
Sobel, J.D.1
-
28
-
-
0035234822
-
Oral versus intravaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush)
-
Cochrane Review
-
Watson MC, Grimshaw JM, Bond CM, et al. Oral versus intravaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Review. Cochrance Database Syst Rev 2001; 4: CD002845.
-
(2001)
Cochrance Database Syst. Rev.
, vol.4
-
-
Watson, M.C.1
Grimshaw, J.M.2
Bond, C.M.3
-
29
-
-
0025650562
-
Patients and doctor preferences in the treatment of vaginal candidiasis
-
Tooley PJ. Patients and doctor preferences in the treatment of vaginal candidiasis. Practitioner 1990; 71: 73-76.
-
(1990)
Practitioner
, vol.71
, pp. 73-76
-
-
Tooley, P.J.1
-
31
-
-
17744404949
-
Prevalence of vaginal colonization by drug-resistant Candida species in college-age women with previous exposure to over-the-counter azole anti-fungals
-
Mathema B, Cross E, Dun E, et al. Prevalence of vaginal colonization by drug-resistant Candida species in college-age women with previous exposure to over-the-counter azole anti-fungals. Clin Infect Dis 2001; 33: 23-27.
-
(2001)
Clin. Infect. Dis.
, vol.33
, pp. 23-27
-
-
Mathema, B.1
Cross, E.2
Dun, E.3
-
32
-
-
0029795294
-
Symptomatic vulvovaginitis due to fluconazole-resistant Candida albicans in a female who was not infected with human immunodeficiency virus
-
Sobel JD, Vasquez JA. Symptomatic vulvovaginitis due to fluconazole-resistant Candida albicans in a female who was not infected with human immunodeficiency virus. Clin Infect Dis 1996; 22: 726-727.
-
(1996)
Clin. Infect. Dis.
, vol.22
, pp. 726-727
-
-
Sobel, J.D.1
Vasquez, J.A.2
-
33
-
-
0036054224
-
Vulvovaginitis due to fluconazole resistant Candida albicans following self treatment with non prescribed triazoles
-
(letter)
-
Dorrell L, Edwards A. Vulvovaginitis due to fluconazole resistant Candida albicans following self treatment with non prescribed triazoles. Sex Transm Infect 2002; 78: 308 (letter).
-
(2002)
Sex Transm. Infect.
, vol.78
, pp. 308
-
-
Dorrell, L.1
Edwards, A.2
-
35
-
-
0034890507
-
Use of fluconazole in daily practice: Still room for improvement
-
Natsch S, Steeghs MH, Hekster YA, Meis JF, van der Meer JW, Kullberg BJ. Use of fluconazole in daily practice: still room for improvement. J Antimicrob Chemother 2001; 48: 303-310.
-
(2001)
J. Antimicrob. Chemother.
, vol.48
, pp. 303-310
-
-
Natsch, S.1
Steeghs, M.H.2
Hekster, Y.A.3
Meis, J.F.4
van der Meer, J.W.5
Kullberg, B.J.6
-
36
-
-
0034919893
-
Decrease in Candida albicans strains with reduced susceptibility to fluconazole following changes in prescribing policies
-
Lopez J, Pernot C, Aho S, et al. Decrease in Candida albicans strains with reduced susceptibility to fluconazole following changes in prescribing policies. J Hosp Infect 2001; 48: 122-128.
-
(2001)
J. Hosp. Infect.
, vol.48
, pp. 122-128
-
-
Lopez, J.1
Pernot, C.2
Aho, S.3
-
37
-
-
0029014172
-
Torulopsis glabrata vaginitis
-
Spinello A, Capuzzo E, Egbe TO, Baltaro F, Nicola S, Piazzi C. Torulopsis glabrata vaginitis. Obstet Gynecol 1995; 85 993-998.
-
(1995)
Obstet. Gynecol.
, vol.85
, pp. 993-998
-
-
Spinello, A.1
Capuzzo, E.2
Egbe, T.O.3
Baltaro, F.4
Nicola, S.5
Piazzi, C.6
-
38
-
-
0030895286
-
Treatment of Candida glabrata vaginitis: Retrospective view of boric acid therapy
-
Sobel JD, Chaim W. Treatment of Candida glabrata vaginitis: retrospective view of boric acid therapy. Clin Infect Dis 1997; 24:649-652.
-
(1997)
Clin. Infect. Dis.
, vol.24
, pp. 649-652
-
-
Sobel, J.D.1
Chaim, W.2
|